Another report shows the diurnal variation in circulating microvesicles (MVs) (CD41+ and Annexin V+) to the severity of obstructive sleep apnea (OSA) and the effect of continuous positive airway pressure treatment implicating the role of MVs in the pathobiology of OSA[126]. This evidence concerns the gene ITGA2B and obstructive sleep apnea syndrome.